KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Current Taxes (2017 - 2020)

Aquestive Therapeutics has reported Current Taxes over the past 4 years, most recently at $316000.0 for Q4 2020.

  • For Q4 2020, Current Taxes rose 5.33% year-over-year to $316000.0; the TTM value through Dec 2020 reached $316000.0, up 5.33%, while the annual FY2020 figure was $316000.0, 5.33% up from the prior year.
  • Current Taxes for Q4 2020 was $316000.0 at Aquestive Therapeutics, down from $370000.0 in the prior quarter.
  • Over five years, Current Taxes peaked at $388000.0 in Q4 2018 and troughed at $176000.0 in Q2 2019.
  • A 4-year average of $312500.0 and a median of $327000.0 in 2018 define the central range for Current Taxes.
  • Biggest five-year swings in Current Taxes: tumbled 33.08% in 2019 and later rose 5.33% in 2020.
  • Year by year, Current Taxes stood at $372000.0 in 2017, then rose by 4.3% to $388000.0 in 2018, then dropped by 22.68% to $300000.0 in 2019, then increased by 5.33% to $316000.0 in 2020.
  • Business Quant data shows Current Taxes for AQST at $316000.0 in Q4 2020, $370000.0 in Q1 2020, and $300000.0 in Q4 2019.